EquityFlow
›
Companies
› Theolytics
Theolytics
Biotech
· Oxford, GB ·
theolytics.com
Oncolytic virus therapeutics for cancer
Funding history
Date
Round
Amount
Jan 2021
Series A
Oxford biotech Theolytics raised a $6.8M Series A co-led by Epidarex Capital and Taiho Ventures, with Oxford Sciences Innovation.
$6.8M
Investors
Epidarex Capital
Oxford Sciences Innovation
Taiho Ventures
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →